Idexx Laboratories Inc
Idexx Laboratories Inc price
About Idexx Laboratories Inc
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Stock ticker
- IDXX
- Company
- IDEXX Laboratories, Inc.
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Jun 21, 1991
- Listed exchange
- NASDAQ
Financials
Summary: IDXX reported Revenue of 1.22B (+9.66%), beating expectations; EPS of 4.27 (+17.63%), beating expectations.
Dividends
Idexx Laboratories Inc conversion tables
 |  |
|---|---|
| 0.5 IDXX | 257.69 USD |
| 1 IDXX | 515.39 USD |
| 5 IDXX | 2,576.95 USD |
| 10 IDXX | 5,153.9 USD |
| |
|---|---|
| 0.5 USD | 0.00097014 IDXX |
| 1 USD | 0.0019403 IDXX |
| 5 USD | 0.0097014 IDXX |
| 10 USD | 0.019403 IDXX |
More to explore
FAQ
IDXX is trading at $515.39, -2.22% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IDXX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IDXX is currently trading at $515.39, -2.22% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IDXX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IDXX's P/E ratio is currently 36.85 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IDXX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IDXX's historical range and other companies in the Healthcare sector.
IDEXX Laboratories, Inc.'s market cap is currently 41.05B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.